It has a significant correlation with worsened outcomes; its upregulation in gastric cancer is shown to promote cancer cell proliferation and is associated with enhanced tumor invasion and HER2 positivity (Li et al., 2020). The gene discussed is ERBB2; the disease is neoplasm.